Skip to content
Open access

Vitis vinifera leaf extract improves quality-of-life and significantly decreases IL-6 levels in patients with chronic venous disease: a prospective, randomized, double-blind, placebo-controlled study.

Oct 2026 · International Angiology · 0 citations
Medicine

TL;DR

It is demonstrated that the V. vinifera-derived supplement reduces numbness/tingling and improves quality-of-life in C2-C3 CVD patients, potentially through inflammatory biomarkers modulation.

Abstract

Background

Phlebotonic medication is an established conservative management approach for Chronic Venous Disease (CVD). This study evaluates whether a new formulation of red vine leaf-containing supplement relieves symptoms, improves quality-of-life and affects oxidative stress and inflammation in C2-C3 CVD patients.

Methods

This prospective, multicenter, randomized, double-blind, placebo-controlled study enrolled 58 participants, allocated 1:1 to self-administer the Vitis vinifera supplement (N.=30) or placebo (N.=28), orally for 8 weeks. Assessments were conducted at baseline and post-intervention. Primary endpoints included changes in clinical symptomatology (Visual Analogue Scale/VAS), leg oedema and calf veins diameter. Secondary outcomes assessed quality-of-life (CIVIQ-20), biomarkers of oxidative stress (malondialdehyde/MDA, protein carbonyls/PCs), inflammation (C-Reactive Protein/CRP, Interleukin-6/IL-6) and endothelial function (Cyclic Guanosine Monophosphate/cGMP) and adverse events incidence. Data analysis was conducted using SPSS and GraphPad Prism.

Results

Mean age was 55.4±11.1 years in the intervention group and 56.2±14.4 in the placebo (P=0.82). Post-treatment, numbness/tingling VAS score significantly reduced in the intervention group compared to placebo (3±3.4 versus 1.33±2.7 points; P=0.040). CIVIQ-20 score reduction was also significantly greater (15.9±14 versus 5.9±15.1; P=0.011). At baseline, there were no significant differences between the V. vinifera supplement and placebo groups in mean ankle or calf circumference. After 8 weeks, both parameters remained comparable between groups. IL-6 levels were significantly reduced in the intervention group to 80.82±8.27pg/mL (baseline 114.7±8.87 pg/mL; P=0.015), whereas the placebo showed a non-significant marginal increase to 103.7±13.55 pg/mL (baseline 89.91±9.2 pg/mL; P=0.41).

Conclusions

We demonstrate that the V. vinifera-derived supplement reduces numbness/tingling and improves quality-of-life in C2-C3 CVD patients, potentially through inflammatory biomarkers modulation.

Read PDF

Similar papers

Open access Oct 2026

Effects of a standardized saffron extract (Safr'Inside™) on menopause-related symptoms: a randomised, double-blind, placebo-controlled trial in perimenopausal women

Menopausal symptoms, which may emerge during perimenopause and include psychological, somatic, vasomotor, and sleep-related disturbances, can substantially impair women's well-being and quality of life. Saffron (Crocus sativus L.) has emerged as a promising non-hormonal nutritional approach, with potential benefits for...

R. Sultana, H. Amjad, H. Zafar et al. · 0 citations
Open access Sep 2026

Effects of grape seed extract on immune-related gene expression, inflammatory biomarkers, disease activity, and quality of life in patients with ulcerative colitis: a randomized, triple-blind, placebo-controlled trial

Grape seed extract (GSE), a polyphenol-rich nutraceutical with antioxidant and anti-inflammatory properties, has shown promising effects in preclinical colitis models; however, clinical evidence in patients with ulcerative colitis (UC) remains limited. This study provides novel clinical evidence in patients with UC...

Azadeh Heydarian, Naheed or Nahid or N or ناهید Aryaeian or ariaeian or آریائیان or آریاییان or, E. Pishgar et al. · 0 citations
Open access Nov 2026

Trigonella Foenum Graecum Seed Extract Attenuated the hs‐ CRP Level in Patients With Myocardial Infarction: A Randomized, Triple‐Blind, Placebo‐Controlled Clinical Trial

This investigation was conducted to explore the effects of Trigonella foenum‐graecum L. (fenugreek) seed extract, an anti‐inflammatory herbal extract, on reducing inflammation in patients diagnosed with myocardial infarction (MI). For this triple‐blind, randomised clinical study, patients with MI were split i...

B. Shahri, V. Askari, M. Ahmadi et al. · 0 citations
Open access Oct 2026

Efficacy and Safety of Lythrum salicaria Extract on Body Fat Reduction in Adults with a BMI of 23–30 kg/m2: A Randomized, Double-Blind, Placebo-Controlled Trial

Background/Objectives: Plant-derived ingredients have attracted interest as adjuncts for reducing body fat, but clinical evidence for Lythrum salicaria extract alone remains limited. We evaluated its effects on body fat and its safety in adults with a body mass index (BMI) of 23–30 kg/m2. Methods: Ninety adults aged 19...

Bong-Jin Shin, Hye-Jin Park, Yea-Jin Park et al. · 0 citations
Open access Nov 2026

Effects of an optimized beta-glucan–based formulation on symptoms, functional capacity, and systemic inflammation in patients with COPD: a randomized controlled trial

Chronic obstructive pulmonary disease (COPD) is characterized by persistent airflow limitation, chronic inflammation, and oxidative stress, leading to progressive functional impairment and reduced quality of life. Beta-glucan possesses immunomodulatory and anti-inflammatory properties, but its therapeutic potenti...

Supamas Napavichayanun, Rungnapha Yamdech, Sarocha Cherdchom et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.